My watch list  

65 Current news about the topic research collaborations


You can refine your search further. Select from the filter options on the left to narrow down your results.

Albany Molecular Research, Inc. Initiates Research Collaboration with Cubist Pharmaceuticals


Albany Molecular Research, Inc. (Nasdaq: AMRI) today announced a drug discovery collaboration with Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) through which the companies hope to identify novel anti-infective drug candidates. Under the terms of the agreement, AMRI will use its proprietary ...


Abgenix And Agensys Enter Technology License Collaboration To Discover And Develop Human Therapeutic Antibodies Against Cancer


Abgenix, Inc. (Nasdaq: ABGX) and Agensys, Inc., a privately-held biotechnology company, announced today a research collaboration, option and license agreement under which the parties will use Abgenix’s human antibody technologies to discover and develop fully human monoclonal antibody ...


Shirley Ann Jackson, Ph.D. elected to Albany Molecular Research, Inc. Board of Directors


Albany Molecular Research, Inc. (Nasdaq: AMRI) today announced the election of Shirley Ann Jackson, Ph.D. to its Board of Directors. This election fills a newly created position. A prominent physicist and university president, Dr. Jackson has served since 1999 as president of Rensselaer ...


Celltech and NeoGenesis Enter Research Collaboration


Celltech Group plc (LSE; CCH; NYSE; CLL) today announced a research collaboration with NeoGenesis, Inc., a privately held biotechnology company based in Cambridge, MA, within which NeoGenesis will use its proprietary chemical genomics technology to identify and optimise new chemical compounds ...


Abgenix Reaches Milestone In Antibody Collaboration With Amgen,


Abgenix, Inc. (NASDAQ: ABGX) today announced that Amgen Inc. (Amgen) has advanced into clinical trials a fully human antibody generated with Abgenix’s technology. This milestone triggers an undisclosed payment to Abgenix. "We are pleased with the productivity of our collaboration with Amgen, ...


Abgenix Enters Xenomouse™ Technology Collaboration With Biogen To Generate Fully Human Antibodies


Abgenix, Inc. (Nasdaq: ABGX) today announced that it has signed a research collaboration, option and license agreement with Biogen, Inc. under which the parties will use Abgenix’s XenoMouse ™ technology to generate fully human monoclonal antibodies to up to fifteen antigen targets supplied by ...


Dow and University of Stuttgart Form Research Collaboration


The Dow Chemical Company and the University of Stuttgart have announced a long-range collaborative research program targeting the improvement of environmental profiles for some plastics, more sustainable industrial processes and new biocatalytic processes to produce pharmaceuticals. Contingent ...


Innovase LLC, a Joint Venture between Dow and Diversa, Announces Research Collaboration with The Procter & Gamble Company


Innovase LLC, a 50/50 joint venture between Diversa Corporation (Nasdaq: DVSA) and The Dow Chemical Company (NYSE: DOW), today announced the signing of a collaboration agreement with The Procter & Gamble Company (NYSE: PG). Under the terms of the agreement, Innovase will discover, optimize and ...


GPC Biotech Announces Proteomics Alliance with Aventis Pharma


GPC Biotech AG (Frankfurt Stock Exchange: GPC), a leading genomics- and proteomics-based drug discovery company, today announced a research collaboration with Aventis Pharma Drug Innovation and Approval (Paris, France) utilizing GPC Biotech's PathCode™ technology to identify and validate ...


MorphoSys Announces Milestone


MorphoSys AG (Neuer Markt: MOR) announced the successful installation of MorphoSys’ fully automated antibody generation system AutoCALTM at the DuPont Pharmaceuticals research facility in Wilmington, DE/USA. AutoCALTM is MorphoSys’ proprietary robotic system that allows high throughput screening ...


Page 6 From 7
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE